Circulating C1q complement/TNF-related protein (CTRP) 1, CTRP9, CTRP12 and CTRP13 concentrations in Type 2 diabetes mellitus: In vivo regulation by glucose

PLoS ONE

Volumn 12, Issue 2, 2017, Pages

  Bai, Bo ^a   Ban, Bo ^a   Liu, Zunjing ^b   Zhang, Man Man ^a   Tan, Bee Kang ^c,d   Chen, Jing ^a,c  

^a JINING MEDICAL UNIVERSITY   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; C1Q COMPONENT TUMOR NECROSIS FACTOR RELATED PROTEIN 1; C1Q COMPONENT TUMOR NECROSIS FACTOR RELATED PROTEIN 12; C1Q COMPONENT TUMOR NECROSIS FACTOR RELATED PROTEIN 13; C1Q COMPONENT TUMOR NECROSIS FACTOR RELATED PROTEIN 9; CHOLESTEROL; ENDOTHELIAL LIPASE; HIGH DENSITY LIPOPROTEIN; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMA PROTEIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; ADIPOCYTOKINE; BIOLOGICAL MARKER; C1QTNF1 PROTEIN, HUMAN; C1QTNF9B PROTEIN, HUMAN; COMPLEMENT COMPONENT C1Q; CTRP13 PROTEIN, HUMAN; FAM132A PROTEIN, HUMAN; GLUCOSE; GLYCOPROTEIN; PROTEIN; SWEETENING AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; IN VIVO STUDY; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PROGNOSIS;

ADIPOKINES; ADIPONECTIN; ADULT; ANIMALS; BIOMARKERS; CASE-CONTROL STUDIES; COMPLEMENT C1Q; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; GLYCOPROTEINS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PROGNOSIS; PROTEINS; SWEETENING AGENTS;

EID: 85012980510     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0172271     Document Type: Article

References (34)

1. Hallschmid M, Randeva H, Tan BK, Kern W, Lehnert H. Relationship between cerebrospinal fluid visfatin (PBEF/Nampt) levels and adiposity in humans. Diabetes. 2009; 58: 637-640. doi: 10.2337/db08- 1176 PMID: 19095760
2. Adya R, Tan BK, Chen J, Randeva HS. Protective actions of globular and full-length adiponectin on human endothelial cells: novel insights into adiponectin-induced angiogenesis. J Vasc Res. 2012; 49: 534-543. doi: 10.1159/000338279 PMID: 22964477
3. Tan BK, Hallschmid M, Adya R, Kern W, Lehnert H, Randeva HS. Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity. Diabetes. 2011; 60: 2758-2762. doi: 10.2337/db11-0672 PMID: 21926274
4. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999; 100: 2473-2476. PMID: 10604883
5. Tan BK, Chen J, Digby JE, Keay SD, Kennedy CR, Randeva HS. Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome. Diabetologia. 2006; 49: 2723-2728. doi: 10.1007/s00125-006-0419-9 PMID: 17001470
6. Ban B, Bai B, Zhang M, Hu J, Ramanjaneya M, Tan BK, et al. Low serum cartonectin/CTRP3 concentrations in newly diagnosed type 2 diabetes mellitus: in vivo regulation of cartonectin by glucose. PLoS One. 2014; 9: e112931. doi: 10.1371/journal.pone.0112931 PMID: 25409499
7. Tan BK, Chen J, Hu J, Amar O, Mattu HS, Adya R, et al. Metformin increases the novel adipokine cartonectin/CTRP3 in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2013; 98: E1891-E1900. doi: 10.1210/jc.2013-2227 PMID: 24152681
8. Peterson JM, Aja S, Wei Z, Wong GW. CTRP1 protein enhances fatty acid oxidation via AMP-activated protein kinase (AMPK) activation and acetyl-CoA carboxylase (ACC) inhibition. J Biol Chem. 2012; 287: 1576-1587. doi: 10.1074/jbc.M111.278333 PMID: 22086915
9. Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, Ge G, Spooner E, Hug C, et al. Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin. FASEB J. 2009; 23: 241-258. doi: 10.1096/fj.08- 114991 PMID: 18787108
10. Enomoto T, Ohashi K, Shibata R, Higuchi A, Maruyama S, Izumiya Y, et al. Adipolin/C1qdc2/CTRP12 protein functions as an adipokine that improves glucose metabolism. J Biol Chem. 2011; 286: 34552-34558. doi: 10.1074/jbc.M111.277319 PMID: 21849507
11. Wei Z, Peterson JM, Wong GW. Metabolic regulation by C1q/TNF-related protein-13 (CTRP13): activation OF AMP-activated protein kinase and suppression of fatty acid-induced JNK signaling. J Biol Chem. 2011; 286: 15652-15665. doi: 10.1074/jbc.M110.201087 PMID: 21378161
12. Ban B, Bai B, Zhang M, Hu J, Ramanjaneya M, Tan BK, et al. Low serum cartonectin/CTRP3 concentrations in newly diagnosed type 2 diabetes mellitus: in vivo regulation of cartonectin by glucose. PLoS One. 2014; 9: e112931. doi: 10.1371/journal.pone.0112931 PMID: 25409499
13. Borch-Johnsen K. The new classification of diabetes mellitus and IGT: a critical approach. Exp Clin Endocrinol Diabetes. 2001; 109 Suppl 2: S86-S93.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-419. PMID: 3899825
15. Prospective Studies Collaboration, Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55, 000 vascular deaths. Lancet. 2007; 370: 1829-1839. doi: 10.1016/S0140-6736(07)61778-4 PMID: 18061058
16. da Luz PL, Favarato D, Faria-Neto JR Jr, Lemos P, Chagas AC. High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. Clinics (Sao Paulo). 2008; 63: 427-432.
17. Han S, Kim JD, Lee S, Jeong AL, Park JS, Yong HJ, et al. Circulating CTRP1 Levels in Type 2 Diabetes and Their Association with FGF21. Int J Endocrinol. 2016; 2016: 5479627. doi: 10.1155/2016/5479627 PMID: 27313611
18. Xin Y, Lyu X, Wang C, Fu Y, Zhang S, Tian C, et al. Elevated circulating levels of CTRP1, a novel adipokine, in diabetic patients. Endocr J. 2014; 61: 841-847. PMID: 24965225
19. Pan X, Lu T, Wu F, Jin L, Zhang Y, Shi L, et al. Circulating complement-C1q TNF-related protein 1 levels are increased in patients with type 2 diabetes and are associated with insulin sensitivity in Chinese subjects. PLoS One. 2014; 9: e94478. doi: 10.1371/journal.pone.0094478 PMID: 24827430
20. Rodriguez S, Lei X, Petersen PS, Tan SY, Little HC, Wong GW. Loss of CTRP1 disrupts glucose and lipid homeostasis. Am J Physiol Endocrinol Metab. 2016; 311: E678-E697. doi: 10.1152/ajpendo. 00087.2016 PMID: 27555298
21. Jeon JH, Kim KY, Kim JH, Baek A, Cho H, Lee YH, et al. A novel adipokine CTRP1 stimulates aldosterone production. FASEB J. 2008; 22: 1502-1511. doi: 10.1096/fj.07-9412com PMID: 18171693
22. Peterson JM, Wei Z, Seldin MM, Byerly MS, Aja S, Wong GW. CTRP9 transgenic mice are protected from diet-induced obesity and metabolic dysfunction. Am J Physiol Regul Integr Comp Physiol. 2013; 305: R522-R533. doi: 10.1152/ajpregu.00110.2013 PMID: 23842676
23. Wei Z, Lei X, Petersen PS, Aja S, Wong GW. Targeted deletion of C1q/TNF-related protein 9 increases food intake, decreases insulin sensitivity, and promotes hepatic steatosis in mice. Am J Physiol Endocrinol Metab. 2014; 306: E779-E790. doi: 10.1152/ajpendo.00593.2013 PMID: 24473438
24. Hwang YC, Woo Oh S, Park SW, Park CY. Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans. Int J Obes (Lond). 2014; 38: 1207-1212.
25. Wolf RM, Steele KE, Peterson LA, Zeng X, Jaffe AE, Schweitzer MA, et al. C1q/TNF-Related Protein-9 (CTRP9) Levels Are Associated With Obesity and Decrease Following Weight Loss Surgery. J Clin Endocrinol Metab. 2016; 101: 2211-2217. doi: 10.1210/jc.2016-1027 PMID: 26982010
26. Jung CH, Lee MJ, Kang YM, Jang JE, Leem J, Lee YL, et al. Association of serum C1q/TNF-related protein- 9 concentration with arterial stiffness in subjects with type 2 diabetes. J Clin Endocrinol Metab. 2014; 99: E2477-E2484. doi: 10.1210/jc.2014-2524 PMID: 25105737
27. Tan BK, Chen J, Adya R, Ramanjaneya M, Patel V, Randeva HS. Metformin increases the novel adipokine adipolin/CTRP12: role of the AMPK pathway. J Endocrinol. 2013; 219: 101-108. doi: 10.1530/JOE-13-0277 PMID: 23946431
28. Tan BK, Chen J, Hu J, Amar O, Mattu HS, Ramanjaneya M, et al. Circulatory changes of the novel adipokine adipolin/CTRP12 in response to metformin treatment and an oral glucose challenge in humans. Clin Endocrinol (Oxf). 2014; 81: 841-846.
29. Wei Z, Peterson JM, Lei X, Cebotaru L, Wolfgang MJ, Baldeviano GC, et al. C1q/TNF-related protein- 12 (CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetes. J Biol Chem. 2012; 287: 10301-10315. doi: 10.1074/jbc.M111.303651 PMID: 22275362
30. Shehzad A, Iqbal W, Shehzad O, Lee YS. Adiponectin: regulation of its production and its role in human diseases. Hormones (Athens). 2012; 11: 8-20.
31. Clément K, Lahlou N, Ruiz J, Hager J, Bougnères P, Basdevant A, et al. Association of poorly controlled diabetes with low serum leptin in morbid obesity. Int J Obes Relat Metab Disord. 1997; 21: 556-561. PMID: 9226485
32. Tan BK, Lewandowski KC, O'Hare JP, Randeva HS. Insulin regulates the novel adipokine adipolin/CTRP12: in vivo and ex vivo effects. J Endocrinol. 2014; 221: 111-119. doi: 10.1530/JOE-13-0537 PMID: 24492466
33. Tan BK, Adya R, Shan X, Syed F, Lewandowski KC, O'Hare JP, et al. Ex vivo and in vivo regulation of lipocalin-2, a novel adipokine, by insulin. Diabetes Care. 2009; 32: 129-131. doi: 10.2337/dc08-1236 PMID: 18852336
34. Huang J, Qian HY, Li ZZ, Zhang JM, Wang S, Tao Y, et al. Role of endothelial lipase in atherosclerosis. Transl Res. 2010; 156: 1-6. doi: 10.1016/j.trsl.2010.05.003 PMID: 20621031